2m 2m 2m 2m 2m 2m 2m
CNS PHARMA (CNSP)
NASDAQ
$4.92$0.00 (0.00%)
Price as of Jun 03, 2026 7:09 PM EDT- $8.0MMarket Cap
- -59.41%1-Year Change
- BiotechnologyIndustry
CNS PHARMA (CNSP)
$4.92$0.00 (0.00%)
CNSP | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.92 | ||
Change | -$0.11 (-2.19%) | ||
Open | $4.93 | ||
High | $5.09 | ||
Low | $4.91 | ||
Previous Close | $5.03 | ||
Volume | 10,242 | ||
30-Day Average Volume | 4,186,082 | ||
1-Week Change | -5.75% | ||
1-Month Change | 112.89% | ||
1-Year Change | -59.41% | ||
3-Year Change | -99.99% | ||
5-Year Change | -100.00% | ||
Fundamentals | |||
Shares Outstanding | 1.5M | ||
Total Assets | $4.7M | ||
Market Cap | $8.0M | ||
Enterprise Value | $5.2M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | -$4.7M | ||
EBIT | $0.00 | ||
EBITDA | $1,868.00 | ||
Net Working Capital | -$504,148.00 | ||
EPS | -$7.30 | ||
Enterprise Value/EBITDA | 2,801 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 112 | ||
P/E | -1 | ||
PEG | N/A | ||
Price/Free Cash Flow | -2 | ||
Price/Operating Cash Flow | -2 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 12 | ||
Last Split Date | 07/22/2025 | ||
Earnings & Revenue